These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 26218744)
21. Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism. Hui KF; Chiang AK Int J Cancer; 2014 Dec; 135(12):2950-61. PubMed ID: 24771510 [TBL] [Abstract][Full Text] [Related]
22. Mitochondrial apoptosis and FAK signaling disruption by a novel histone deacetylase inhibitor, HTPB, in antitumor and antimetastatic mouse models. Shieh JM; Wei TT; Tang YA; Huang SM; Wen WL; Chen MY; Cheng HC; Salunke SB; Chen CS; Lin P; Chen CT; Wang YC PLoS One; 2012; 7(1):e30240. PubMed ID: 22279574 [TBL] [Abstract][Full Text] [Related]
23. Induction of apoptosis in MDA-MB-231 human breast carcinoma cells with an ethanol extract of Cyperus rotundus L. by activating caspases. Park SE; Shin WT; Park C; Hong SH; Kim GY; Kim SO; Ryu CH; Hong SH; Choi YH Oncol Rep; 2014 Dec; 32(6):2461-70. PubMed ID: 25241797 [TBL] [Abstract][Full Text] [Related]
24. Induction of MAPK- and ROS-dependent autophagy and apoptosis in gastric carcinoma by combination of romidepsin and bortezomib. Hui KF; Yeung PL; Chiang AK Oncotarget; 2016 Jan; 7(4):4454-67. PubMed ID: 26683357 [TBL] [Abstract][Full Text] [Related]
25. Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines. Hui KF; Leung YY; Yeung PL; Middeldorp JM; Chiang AK Br J Haematol; 2014 Dec; 167(5):639-50. PubMed ID: 25155625 [TBL] [Abstract][Full Text] [Related]
26. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells. Kuo PL; Chen CY; Hsu YL Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211 [TBL] [Abstract][Full Text] [Related]
27. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells. Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585 [TBL] [Abstract][Full Text] [Related]
28. Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cells. Karthik S; Sankar R; Varunkumar K; Ravikumar V Biomed Pharmacother; 2014 Apr; 68(3):327-34. PubMed ID: 24485799 [TBL] [Abstract][Full Text] [Related]
29. Discovery of N-hydroxy-4-(3-phenylpropanamido)benzamide derivative 5j, a novel histone deacetylase inhibitor, as a potential therapeutic agent for human breast cancer. Feng J; Fang H; Wang X; Jia Y; Zhang L; Jiao J; Zhang J; Gu L; Xu W Cancer Biol Ther; 2011 Mar; 11(5):477-89. PubMed ID: 21263218 [TBL] [Abstract][Full Text] [Related]
30. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines. Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085 [TBL] [Abstract][Full Text] [Related]
31. LHRH-Targeted Redox-Responsive Crosslinked Micelles Impart Selective Drug Delivery and Effective Chemotherapy in Triple-Negative Breast Cancer. Xiao K; Liu Q; Suby N; Xiao W; Agrawal R; Vu M; Zhang H; Luo Y; Li Y; Lam KS Adv Healthc Mater; 2021 Feb; 10(3):e2001196. PubMed ID: 33200571 [TBL] [Abstract][Full Text] [Related]
32. Blocking NF-κB sensitizes non-small cell lung cancer cells to histone deacetylase inhibitor induced extrinsic apoptosis through generation of reactive oxygen species. Karthik S; Sankar R; Varunkumar K; Anusha C; Ravikumar V Biomed Pharmacother; 2015 Feb; 69():337-44. PubMed ID: 25661379 [TBL] [Abstract][Full Text] [Related]
33. The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21. Son DS; Wilson AJ; Parl AK; Khabele D Cancer Biol Ther; 2010 Jun; 9(11):928-35. PubMed ID: 20404564 [TBL] [Abstract][Full Text] [Related]
34. Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors. Saijo K; Imamura J; Narita K; Oda A; Shimodaira H; Katoh T; Ishioka C Cancer Sci; 2015 Feb; 106(2):208-15. PubMed ID: 25492515 [TBL] [Abstract][Full Text] [Related]
35. An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells. Reddy ND; Shoja MH; Biswas S; Nayak PG; Kumar N; Rao CM Chem Biol Interact; 2016 Jun; 253():112-24. PubMed ID: 27163855 [TBL] [Abstract][Full Text] [Related]
36. Actively-targeted polyion complex micelles stabilized by cholesterol and disulfide cross-linking for systemic delivery of siRNA to solid tumors. Oe Y; Christie RJ; Naito M; Low SA; Fukushima S; Toh K; Miura Y; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K Biomaterials; 2014 Sep; 35(27):7887-95. PubMed ID: 24930854 [TBL] [Abstract][Full Text] [Related]
37. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line. Duo J; Ma Y; Wang G; Han X; Zhang C DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817 [TBL] [Abstract][Full Text] [Related]
38. Phosphodiesterase inhibitor, pentoxifylline enhances anticancer activity of histone deacetylase inhibitor, MS-275 in human breast cancer in vitro and in vivo. Nidhyanandan S; Boreddy TS; Chandrasekhar KB; Reddy ND; Kulkarni NM; Narayanan S Eur J Pharmacol; 2015 Oct; 764():508-519. PubMed ID: 26209365 [TBL] [Abstract][Full Text] [Related]
39. The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy. Karam JA; Fan J; Stanfield J; Richer E; Benaim EA; Frenkel E; Antich P; Sagalowsky AI; Mason RP; Hsieh JT Int J Cancer; 2007 Apr; 120(8):1795-802. PubMed ID: 17230511 [TBL] [Abstract][Full Text] [Related]
40. Romidepsin (FK228), A Histone Deacetylase Inhibitor and its Analogues in Cancer Chemotherapy. Pojani E; Barlocco D Curr Med Chem; 2021; 28(7):1290-1303. PubMed ID: 32013816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]